CSF1R and B-cell chronic lymphocytic leukemia: In a mouse model of chronic lymphocytic leukemia, targeting MΦs using an anti-CSF1R mAb efficiently inhibited disease progression; interestingly, the leukemic cell death was dependent on TNF-α signaling and tumor microenvironment reprogramming toward an antitumoral phenotype [78].